CAMP4 Therapeutics Corporation Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for the quarter ending 2025-09-30 was $29.19M, a 94064.52% increase year-over-year.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for the quarter ending 2024-09-30 was $31.00K, a 3000.00% increase year-over-year.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for the quarter ending 2024-03-31 was $2.00K, a 71.43% decline year-over-year.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for fiscal 2025 was $57.31M, a 20.81% decline from fiscal 2024.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for fiscal 2024 was $72.37M, a 39020.54% increase from fiscal 2023.
- CAMP4 Therapeutics Corporation stock issued during period, value, new issues for fiscal 2023 was $185.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $57.31M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $29.19M 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $72.37M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $31.00K 10-Q · filed 2024-11-21 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $2.00K 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $185.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-21 | |
| 2023-06-30 | $4.00K 10-Q · filed 2024-11-21 | |
| 2023-03-31 | $7.00K 10-Q · filed 2024-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |